Table 1 Characteristics of study participants at M24
N or mean + SD | ||
|---|---|---|
Sex | Male | 106 |
Female | 287 | |
Professional category | Nurse/auxiliary/stretcher-bearer | 192 |
Physician | 93 | |
Lab technician | 14 | |
Admin officers/other | 94 | |
Age | 46.7 ± 11.2 | |
Comorbidities | Yes | 117 |
No | 276 | |
Comorbidity categorya | Cardiovascular | 41 |
Respiratory disease | 33 | |
Endocrine | 33 | |
Gastrointestinal | 12 | |
Neurological | 10 | |
Dermatological | 10 | |
Immunosuppression | 6 | |
Hematological | 4 | |
Cancer | 4 | |
Liver | 3 | |
Gynecological | 3 | |
Mental health | 3 | |
Immunological | 2 | |
Otherb | 111 | |
Chronic medicationa | Yes | 92 |
No | 25 | |
Smoker | Yes | 79 |
No | 313 | |
NA | 1 | |
No. of people in the household | 2.8 ± 1.3 | |
Involved in clinical care | Yes | 285 |
No | 108 | |
1st dose vaccination | Pfizer | 251 |
Moderna | 131 | |
2nd dose vaccination | Pfizer | 248 |
Moderna | 122 | |
3rd dose vaccination | Pfizer | 2 |
Moderna | 285 | |
Number of doses received | 0 | 11 |
1 | 12 | |
2 | 83 | |
3 | 287 | |
Breakthrough infection (post M24) | Yes | 109 |
Among vaccinated with 2 or 3 doses | No | 261 |